Robyn Glaesser, MD
Dermatology · Tucson, AZNPI 1831191741
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,477 of the $8,750 with a category attached, or 62.6%. 26 manufacturers reported payments, led by LEO Pharma Inc. at 31.8% of the total. Reporting peaked in 2022 at $2,754 and has fallen 81.7% since, to $504 in 2025.
Across 307 payments — averaging $28.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$3K
- Sanofi$2K
- AbbVie$659
- Novartis$523
- Johnson & Johnson$441
- Pfizer$410
- plus $2K from 20 others
What the payments were for
- Consulting fees$2,27026%
- Travel & lodging$7378%
- Food & beverage$5,47763%
- Education$2653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 59 | $2,781 |
| Sanofi | 33 | $2,076 |
| AbbVie(2 entities) | 34 | $659 |
| Novartis | 26 | $523 |
| Johnson & Johnson | 30 | $441 |
| Pfizer | 38 | $410 |
| Sun Pharmaceutical Industries Inc. | 15 | $338 |
| Regeneron Healthcare Solutions, Inc. | 14 | $276 |
| Sanofi-aventis U.S. LLC | 3 | $262 |
| UCB, Inc. | 7 | $182 |
| Galderma Laboratories, L.p. | 8 | $159 |
| Amgen | 8 | $155 |
| Lilly USA, LLC | 4 | $72 |
| Prugen, Inc. Pharmaceuticals | 5 | $53 |
| Mayne Pharma Commercial LLC | 4 | $53 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
| EPI Health, LLC | 4 | $38 |
| Dermavant Sciences, Inc. | 2 | $37 |
| Bristol Myers Squibb | 2 | $32 |
| DUSA Pharmaceuticals, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Biofrontera Inc. | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
| Incyte Corporation | 1 | $15 |
| Dermira, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,750 in reported general payments places this provider in the 80th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 54 | $203,417 |
| Fluorouracil | 93 | $5,536 |
| Clobetasol Propionate | 125 | $5,426 |
| Finasteride | 402 | $5,202 |
| Triamcinolone Acetonide | 287 | $3,221 |
| Fluocinonide | 87 | $2,897 |
| Fluconazole | 112 | $2,593 |
| Metronidazole | 42 | $2,117 |
| Ketoconazole | 118 | $1,994 |
| ValacyclovirValacyclovir Hcl | 81 | $1,968 |
| Doxepin Hcl | 86 | $1,878 |
| Clindamycin Phosphate | 46 | $1,247 |
| Betamethasone Dipropionate | 22 | $939 |
| Imiquimod | 20 | $630 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 12 | $597 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tucson
- Kathleen ObrienTucson$742K
- James SlighTucson$238K
- Clara CurielTucson$20K
- Elka EisenTucson$15K
- Scott SheftelTucson$11K
- Matthew BealTucson$9K
- Lindsay AckermanPhoenix$1.6M
- Nathalie ZeitouniPhoenix$584K
- John KastelerGilbert$456K
- Anthony NuaraScottsdale$432K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.